Technology And Equipment Tenders

Drug Contracts with Accession Option

Medicines with the Active Ingredient Rivaroxaban (Atc: B01af01 - in all Potencies Except 2.5 Mg Per Divided Oral Dosage Form)

Medicines with the Active Ingredient Rivaroxaban (Atc: B01af01 - with a Potency of 2.5 Mg Per Divided Oral Dosage Form)

Open House Original Discount Agreements 2024-04 - Cariprazine

Drug Contracts with Accession Option

Medicines with the Active Ingredient Testosterone (Atc: G03ba03 - in the Dosage Form Injection Solution)

Property Planning (Lph 1 - 9 According to Hoai 2021) and Requirements Planning (Phase Zero) for the Expansion of the Unesco School - 2Nd Construction Phase in Kamp-Lintfort

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130 a Paragraph 8 Sgb V with the Active Ingredient Ranibizumab

Conclusion of Non-Exclusive Discount Agreements in Accordance with Sections 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicines with the Active Ingredient Lipegfilgrastim (L03aa14) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V with the Active Ingredient Bevacizumab